Licensing Opportunities Offered to Manufacturers To Use Clinically Studied Claims
LOS ANGELES, March 2 (Bernama-GLOBE NEWSWIRE) -- Axiom Foods, Inc. (“Axiom”) has been awarded its first application patent for any rice protein ever, U.S. Patent No. 9,820,504 for its Oryzatein® rice protein; Axiom Foods is one of the largest makers of rice and pea protein ingredients. Allowed as of November 11, 2017, the “method of use” protection grants exclusive right to Axiom to use the clinically-shown product claims for multiple versions of Axiom’s Oryzatein® organic brown rice protein, specifically: increased muscle mass, increased strength, increased power output, a decrease in fat to muscle ratio, increased VO2 max, and increased endurance. This is the first of multiple patents pending for Axiom’s Oryzatein® rice protein, with clinical studies to support them. Any rice protein manufacturers and finished product manufacturers using other rice proteins in conjunction with any of the above muscle and endurance-related claims in sports formulations, will be in violation of the patent and Axiom will enforce infringement to the maximum extent of the law.
The now protected Axiom’s Oryzatein® product claims are based on clinical trials which showed that Oryzatein® brown rice protein now equals animal-based whey protein in muscle building, maintenance and recovery. Other clinical trials using Oryzatein® have shown that the muscle-building amino acid, leucine, absorbs faster than other rice proteins and whey proteins. The trials were published in the Nutrition Journal in 2013, the Journal of Nutrition & Health Sciences in 2014 and the International Journal of the Society of Sports Nutrition in 2017.
LOS ANGELES, March 2 (Bernama-GLOBE NEWSWIRE) -- Axiom Foods, Inc. (“Axiom”) has been awarded its first application patent for any rice protein ever, U.S. Patent No. 9,820,504 for its Oryzatein® rice protein; Axiom Foods is one of the largest makers of rice and pea protein ingredients. Allowed as of November 11, 2017, the “method of use” protection grants exclusive right to Axiom to use the clinically-shown product claims for multiple versions of Axiom’s Oryzatein® organic brown rice protein, specifically: increased muscle mass, increased strength, increased power output, a decrease in fat to muscle ratio, increased VO2 max, and increased endurance. This is the first of multiple patents pending for Axiom’s Oryzatein® rice protein, with clinical studies to support them. Any rice protein manufacturers and finished product manufacturers using other rice proteins in conjunction with any of the above muscle and endurance-related claims in sports formulations, will be in violation of the patent and Axiom will enforce infringement to the maximum extent of the law.
The now protected Axiom’s Oryzatein® product claims are based on clinical trials which showed that Oryzatein® brown rice protein now equals animal-based whey protein in muscle building, maintenance and recovery. Other clinical trials using Oryzatein® have shown that the muscle-building amino acid, leucine, absorbs faster than other rice proteins and whey proteins. The trials were published in the Nutrition Journal in 2013, the Journal of Nutrition & Health Sciences in 2014 and the International Journal of the Society of Sports Nutrition in 2017.
No comments:
Post a Comment